These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 26153458)

  • 1. Editorial Comment from Dr Nakamura to Identification of a subgroup with worse prognosis among patients with poor-risk testicular germ cell tumor.
    Nakamura T
    Int J Urol; 2015 Oct; 22(10):928. PubMed ID: 26153458
    [No Abstract]   [Full Text] [Related]  

  • 2. Editorial Comment from Dr O'Carrigan and Dr Grimison to Identification of a subgroup with worse prognosis among patients with poor-risk testicular germ cell tumor.
    O'Carrigan B; Grimison P
    Int J Urol; 2015 Oct; 22(10):928-9. PubMed ID: 26173657
    [No Abstract]   [Full Text] [Related]  

  • 3. Editorial Comment from Dr Beyer to Identification of a subgroup with worse prognosis among patients with poor-risk testicular germ cell tumor.
    Beyer J
    Int J Urol; 2015 Oct; 22(10):929-30. PubMed ID: 26105542
    [No Abstract]   [Full Text] [Related]  

  • 4. Identification of a subgroup with worse prognosis among patients with poor-risk testicular germ cell tumor.
    Kojima T; Kawai K; Tsuchiya K; Abe T; Shinohara N; Tanaka T; Masumori N; Yamada S; Arai Y; Narita S; Tsuchiya N; Habuchi T; Nishiyama H
    Int J Urol; 2015 Oct; 22(10):923-7. PubMed ID: 26094715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and management of poor risk patients with germ cell tumors: the Memorial Sloan-Kettering Cancer Center experience.
    Bosl GJ; Geller NL; Bajorin D
    Semin Oncol; 1988 Aug; 15(4):339-44. PubMed ID: 2841764
    [No Abstract]   [Full Text] [Related]  

  • 6. [Management of metastatic testicular germ cell tumors].
    Lavaud P; Baciarello G; Fizazi K
    Bull Cancer; 2019 Oct; 106(10):896-902. PubMed ID: 31466695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical features and management of testicular germ cell tumours in patients aged 60 years and older.
    Berney DM
    BJU Int; 2011 Nov; 108(9):E312; author's reply E312-3. PubMed ID: 22023064
    [No Abstract]   [Full Text] [Related]  

  • 8. Testicular germ cell tumors. Clinically relevant pathologic findings.
    Ro JY; Dexeus FH; el-Naggar A; Ayala AG
    Pathol Annu; 1991; 26 Pt 2():59-87. PubMed ID: 1650448
    [No Abstract]   [Full Text] [Related]  

  • 9. Classification, epidemiology and therapies for testicular germ cell tumours.
    Vasdev N; Moon A; Thorpe AC
    Int J Dev Biol; 2013; 57(2-4):133-9. PubMed ID: 23784823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of Germ Cell Cancer: Lessons Learned From a National Database.
    de Wit R
    J Clin Oncol; 2015 Oct; 33(28):3078-9. PubMed ID: 26304873
    [No Abstract]   [Full Text] [Related]  

  • 11. The Danish Testicular Carcinoma Study. Results from recent clinical trials in non-seminomatous tumours.
    Schultz HP; Rørth M; von der Maase H; Sandberg E; Pedersen M
    Acta Urol Belg; 1985; 53(2):362-76. PubMed ID: 2990182
    [No Abstract]   [Full Text] [Related]  

  • 12. Management of germ cell tumors of the adult testis at the Memorial Sloan Kettering Cancer Center.
    Whitmore WF; Bosl G
    Acta Urol Belg; 1985; 53(2):341-61. PubMed ID: 2990181
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of non-seminomatous testicular germ cell tumors in Denmark since 1979.
    Rørth M; von der Maase H; Nielsen ES; Schultz H; Pedersen M
    Prog Clin Biol Res; 1985; 203():539-51. PubMed ID: 3008183
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of advanced disseminated germ cell tumors.
    Einhorn LH
    Ann Oncol; 1991 Mar; 2(3):167-8. PubMed ID: 1645987
    [No Abstract]   [Full Text] [Related]  

  • 15. Testicular cancer--discoveries and updates.
    Hanna NH; Einhorn LH
    N Engl J Med; 2014 Nov; 371(21):2005-16. PubMed ID: 25409373
    [No Abstract]   [Full Text] [Related]  

  • 16. [Primary testicular tumors in children].
    Beresi V; del Pozo H; Quintana J; Latorre JJ; Izzo C
    Rev Chil Pediatr; 1987; 58(1):69-73. PubMed ID: 2450388
    [No Abstract]   [Full Text] [Related]  

  • 17. High dose chemotherapy followed by autologous bone marrow re-infusion in relapsing or refractory testicular cancer.
    Sleijfer DT; Mulder PO; de Vries EG; Koops HS; Willemse PH; Sibinga CT; Mulder NH
    Prog Clin Biol Res; 1988; 269():429-37. PubMed ID: 2839849
    [No Abstract]   [Full Text] [Related]  

  • 18. The Changing Landscape of Intermediate- and Poor-Risk Germ Cell Tumors: Do We Need to Reclassify Patients With Metastatic Germ Cell Tumors?
    Necchi A; Nicolai N; Giannatempo P; Raggi D; Miceli R; Mariani L; Salvioni R
    Clin Genitourin Cancer; 2016 Feb; 14(1):1-4. PubMed ID: 26329776
    [No Abstract]   [Full Text] [Related]  

  • 19. Personal experience in the management of germinal testis tumors.
    Pizzocaro G
    Acta Urol Belg; 1985; 53(2):377-93. PubMed ID: 2990183
    [No Abstract]   [Full Text] [Related]  

  • 20. Pre-orchiectomy tumor marker levels should not be used for International Germ Cell Consensus Classification (IGCCCG) risk group assignment.
    Fankhauser CD; Gerke TA; Roth L; Sander S; Grossmann NC; Kranzbühler B; Eberli D; Sulser T; Beyer J; Hermanns T
    J Cancer Res Clin Oncol; 2019 Mar; 145(3):781-785. PubMed ID: 30637464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.